SYSTM Wealth Solutions’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-4,756
Closed -$198K 161
2024
Q2
$198K Sell
4,756
-61,433
-93% -$2.75M 0.04% 187
2024
Q1
$3.59M Sell
66,189
-7,851
-11% -$400K 0.45% 58
2023
Q4
$3.8M Sell
74,040
-334
-0.4% -$17.5K 0.53% 47
2023
Q3
$4.32M Buy
74,374
+1,420
+2% +$87K 0.66% 34
2023
Q2
$4.67M Sell
72,954
-24
-0% -$1.61K 0.63% 33
2023
Q1
$5.06M Buy
72,978
+16,536
+29% +$1.17M 0.78% 25
2022
Q4
$4.06M Buy
+56,442
New +$4.26M 0.5% 48

Other funds holding BMY

SYSTM Wealth Solutions's BMY Position: Q3 2024 in Review

SYSTM Wealth Solutions sold out of Bristol-Myers Squibb (BMY) in Q3 2024, closing a stake of 4,756 shares — an estimated $198K sold.

SYSTM Wealth Solutions first reported a position in BMY in Q4 2022 and held it in 7 quarters. The position peaked at $5.06M in Q1 2023. 2,258 funds tracked by Wall St. Rank hold BMY as of Q3 2024.

  • SYSTM Wealth Solutions reported no remaining Bristol-Myers Squibb position as of Q3 2024 after selling out during the quarter.
  • SYSTM Wealth Solutions sold 4,756 Bristol-Myers Squibb shares in Q3 2024, an estimated $198K.
  • SYSTM Wealth Solutions first reported a position in Bristol-Myers Squibb in Q4 2022 and held it in 7 quarters.
  • SYSTM Wealth Solutions's Bristol-Myers Squibb position peaked at $5.06M in Q1 2023.
  • 2,258 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2024.

Based on SYSTM Wealth Solutions's 13F filing for Q3 2024, filed 14 Nov 2024.